Matches in Wikidata for { <http://www.wikidata.org/entity/Q91212924> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q91212924 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91212924 description "scientific article published on 09 November 2019" @default.
- Q91212924 description "wetenschappelijk artikel" @default.
- Q91212924 description "наукова стаття, опублікована 9 листопада 2019" @default.
- Q91212924 name "A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study" @default.
- Q91212924 name "A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study" @default.
- Q91212924 type Item @default.
- Q91212924 label "A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study" @default.
- Q91212924 label "A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study" @default.
- Q91212924 prefLabel "A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study" @default.
- Q91212924 prefLabel "A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study" @default.
- Q91212924 P1433 Q91212924-242114CC-1931-4E4C-82BC-69F53912C859 @default.
- Q91212924 P1476 Q91212924-C8FD5B8C-C5DA-4064-8DFE-7C537EE1640C @default.
- Q91212924 P2093 Q91212924-0345796A-FFE2-44CC-B05E-638515008DBE @default.
- Q91212924 P2093 Q91212924-15793EDC-C576-42CA-899D-609BFC6DE35C @default.
- Q91212924 P2093 Q91212924-2340C32E-49BF-4275-B852-5A6E0AA13367 @default.
- Q91212924 P2093 Q91212924-47ED4D4C-D4E3-41E2-8AC6-5E5851F183DD @default.
- Q91212924 P2093 Q91212924-50BEF4F0-4B0A-4C3E-A58E-01EA83376B6A @default.
- Q91212924 P2093 Q91212924-665FF588-D6E7-4B68-A7A8-E89E01FC8850 @default.
- Q91212924 P2093 Q91212924-68F29C91-15DF-454A-AC35-AD348498BA12 @default.
- Q91212924 P2093 Q91212924-6EB82D66-7A12-468F-8A0C-CF158F5A9FEF @default.
- Q91212924 P2093 Q91212924-72655A6A-C488-4BAA-9EE7-758358981307 @default.
- Q91212924 P2093 Q91212924-8AFEFD1F-8D75-45C9-B35E-D4F035EF6241 @default.
- Q91212924 P2093 Q91212924-955B12CC-D16C-4913-A5CF-AF60C07BC219 @default.
- Q91212924 P31 Q91212924-9E90A6C2-6D4C-474A-96B6-E2A15D7E17B3 @default.
- Q91212924 P356 Q91212924-43EC5D65-90BA-42BD-AB11-44F30E4414FF @default.
- Q91212924 P50 Q91212924-9A630C4C-B8D2-4388-BCF6-AE258DCFA1BF @default.
- Q91212924 P577 Q91212924-2EDF0B53-E2A0-40DE-BFC6-FD35E2044E80 @default.
- Q91212924 P698 Q91212924-0486418C-A8BE-463D-8915-90CC3CD9D657 @default.
- Q91212924 P921 Q91212924-4A7B6E30-ED05-4048-94A5-6D7B82E42F1E @default.
- Q91212924 P356 S10637-019-00875-4 @default.
- Q91212924 P698 31707687 @default.
- Q91212924 P1433 Q2312231 @default.
- Q91212924 P1476 "A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study" @default.
- Q91212924 P2093 "Craig Harlos" @default.
- Q91212924 P2093 "Dongsheng Tu" @default.
- Q91212924 P2093 "H Artee Luchman" @default.
- Q91212924 P2093 "Joana Sederias" @default.
- Q91212924 P2093 "John P Rossiter" @default.
- Q91212924 P2093 "Lesley Seymour" @default.
- Q91212924 P2093 "Mary MacNeil" @default.
- Q91212924 P2093 "Roger Tsang" @default.
- Q91212924 P2093 "Samuel Weiss" @default.
- Q91212924 P2093 "Sarah Lapointe" @default.
- Q91212924 P2093 "Warren Mason" @default.
- Q91212924 P31 Q13442814 @default.
- Q91212924 P356 "10.1007/S10637-019-00875-4" @default.
- Q91212924 P50 Q86351549 @default.
- Q91212924 P577 "2019-11-09T00:00:00Z" @default.
- Q91212924 P698 "31707687" @default.
- Q91212924 P921 Q282142 @default.